Trial intelligence / Profile preview

Parecoxib plus morphine multimodal analgesia for postoperative delirium in elderly non-cardiac surgery patients

ChiCTR-TRC-10001063Phase 4Completed

Sponsor
Beijing Hospital
Start
Dec 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of parecoxib and morphine in postoperative pain and postoperative delirium (POD) (2 arms), sponsored by Beijing Hospital. Primary endpoints: Pain at rest and with movement and Postoperative delirium diagnosis. Started Dec 2010; status: completed.

02

Drugs

parecoxibmorphine
03

Conditions

postoperative painpostoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR-TRC-10001063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call